The prospective study on the safety of metalic markers for radiotherapy of gynecological cancer

The prospective study on the safety of metalic markers for radiotherapy of gynecological cancer - The safety of metal markers for radiotherapy of gynecological cancer

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000023449

Enrollment

Registered

2016-08-04

Start date

2016-07-28

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervical cancer, Endometrial cancer, Vaginal cancer, Vulvar cancer

Interventions

Implantation of metalic markers into tumors or the tissue close to tumors

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Cervical cancer, Uterine endometrial cancer, Vaginal cancer, Vulvar cancer; PS 0-2; benefit of marker implantation Written informed consent.

Exclusion criteria

Exclusion criteria: Coagulation disorder; Severe coexisting disease; Pregnancy, possible pregnancy.

Design outcomes

Primary

Measure	Time frame
Sever complications within 3 months after the implantation of metalic markers.	—

Countries

Japan

Contacts

Public ContactSHUHEI SEKII

Hyogo Cancer Center Department of Radiation Oncology

ssekii@hp.pref.hyogo.jp078-929-1151

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026